STOCK TITAN

Aramark (ARMK) SEC Filings, Aug-Sep 2026

ARMK NYSE

Aramark (ARMK) filings document a Delaware operating company with NYSE-listed common stock and a business centered on food, facilities management, hospitality, and support services. Its 8-K reports include operating results, material definitive agreements, annual meeting voting results, and compensation matters involving restricted stock units and executive equity awards.

Proxy materials disclose board elections, auditor ratification, executive compensation, equity awards, shareholder voting matters, and governance practices. Financing filings also describe amendments to the credit agreement of Aramark Services, Inc., an indirect wholly owned subsidiary, including term-loan refinancing and repricing transactions within the company’s capital structure.

Rhea-AI Summary

Aramark (symbol: ARMK) is the issuer of record for a Form 4 filing submitted to the SEC. King Karen Marie reported acquisition or exercise transactions in this Form 4 filing.

Aramark (ARMK) reported that director Karen Marie King received an award of 24.471 shares of Common Stock equivalents on September 9, 2026. These represent dividend equivalent rights that accrued on her deferred stock units in connection with Aramark’s quarterly dividend and vest on the same schedules as the underlying awards. Following this award, she holds 42,827.279 common-share equivalents directly. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
insider
-
Rhea-AI Summary

Aramark (ARMK) director Patricia E. Lopez reported an automatic acquisition of 61.449 shares of common stock-equivalent units on September 9, 2026. These represent dividend equivalent rights credited on her deferred stock units in connection with Aramark’s quarterly dividend, bringing her directly held total to 29,203.826 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
insider
-
Rhea-AI Summary

Aramark (symbol: ARMK) is the issuer of record for a Form 4 filing submitted to the SEC. SADOVE STEPHEN I reported acquisition or exercise transactions in this Form 4 filing.

Aramark (ARMK) director Stephen I. Sadove reported an automatic grant of 187.656 common-share equivalents on September 9, 2026, described as dividend equivalent rights that accrued on his deferred stock units in connection with Aramark’s quarterly dividend. The rights were received at no cash price and vest on the same schedule as the underlying awards, bringing his directly held common stock (including deferred units) to 102,694.423 shares. He also reports 15,000 shares held indirectly by a trust. No Rule 10b5-1 trading plan is reported for these holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
insider
Rhea-AI Summary

Aramark (ARMK) reported that director Kevin Wills acquired additional common stock-related rights on September 9, 2026 through a grant classified as a grant, award, or other acquisition tied to existing deferred stock units. The filing states this represents 34.551 dividend equivalent rights accruing from the company’s quarterly dividend, bringing his directly held common stock-related position to 21,974.546 shares after the transaction. These dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
insider
-
Rhea-AI Summary

Aramark (ARMK) reports that EVP and CFO James J. Tarangelo exercised stock options for 8,852 shares of Common Stock on September 3, 2026 at an exercise price of $24.58 per share. In connection with this fully vested option, 6,048 shares of Common Stock were delivered or withheld to satisfy the payment of the exercise price and tax withholding obligations. These options were scheduled to expire on November 18, 2026, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.41%
Tags
insider
-
Rhea-AI Summary

Aramark COO, U.S. Food & Facilities Marc A. Bruno reported a series of option exercises and related share dispositions on August 13, 2026. He exercised 210,402 stock options into an equal number of Aramark common shares at exercise prices of $24.58, $29.38, and $26.50 per share on fully vested options that were scheduled to expire between November 2026 and November 2028.

To cover the option exercise price and tax withholding obligations, 139,768 shares of common stock were withheld by Aramark. In addition, Bruno sold 55,245 shares at a weighted average price of $60.92 per share (in trades ranging from $60.35 to $61.34) and 15,389 shares at a weighted average price of $61.42 per share (ranging from $61.35 to $61.50). Overall, the transactions combine option exercises, shares withheld for costs, and open-market sales.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
insider
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags
other
-
Rhea-AI Summary

Aramark filed an initial statement of beneficial ownership identifying Antony Spring as a director. The filing reports no non-derivative or derivative holdings and no transactions. It also includes an Exhibit 24 Power of Attorney authorizing certain actions on the reporting person’s behalf.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.20%
Tags
insider
-
Rhea-AI Summary

Aramark reported higher sales and profits for the quarter and nine months ended July 3, 2026. Quarterly revenue rose to $5.06 billion, up 9.3% year over year, while operating income increased 18.1% to $215.6 million. Net income attributable to stockholders was $97.7 million (diluted EPS $0.36), up from $71.8 million ($0.27) a year earlier.

For the first nine months, revenue reached $14.80 billion, up 9.9%, and net income attributable to stockholders grew 23.7% to $295.8 million (diluted EPS $1.11). Growth was driven by base business and new contracts across U.S. and international operations, with especially strong gains in Business & Industry, Sports, Leisure & Corrections, and key European markets, partly offset by fewer service days due to a prior-year 53-week fiscal calendar.

Cash from operating activities was a use of $264.8 million over nine months, while net cash from financing of $563.6 million and increased long-term borrowings (now $6.13 billion) supported investments and refinancing. Aramark ended the period with $499.4 million in cash and $914.9 million of revolver availability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.20%
Tags
quarterly report
Rhea-AI Summary

Aramark reported stronger third-quarter fiscal 2026 results, with revenue of $5.06 billion versus $4.63 billion a year earlier, an increase of 9.3%. Operating income rose to $215.6 million from $182.6 million, and net income attributable to stockholders increased to $97.7 million from $71.8 million. Diluted EPS was $0.36, up from $0.27, while adjusted EPS was $0.52 compared with $0.40, a 30.0% increase.

By segment, FSS United States and FSS International both delivered double-digit operating income growth, supported by higher base and new business and supply chain efficiencies, though corporate expenses rose on higher share-based compensation. Free Cash Flow for the quarter turned positive at $8.7 million versus negative $33.6 million, and the company ended the quarter with $499.4 million in cash and cash equivalents and over $1.4 billion in total cash availability.

Net Debt to Covenant Adjusted EBITDA improved to 3.5x from 4.0x, and Aramark repaid about $100 million of 2028 Term Loans after quarter-end. Management raised its fiscal 2026 organic revenue growth outlook to +9% to +10% and reaffirmed expectations for AOI growth of +12% to +17%, adjusted EPS growth of +20% to +25%, and a leverage ratio under 3x. The company highlighted new hyperscaler and AI data center engagements under Aramark Nexus and declared a $0.12-per-share quarterly dividend.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.54%
Tags
current report

FAQ

How many Aramark (ARMK) SEC filings are available on StockTitan?

StockTitan tracks 171 SEC filings for Aramark (ARMK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Aramark (ARMK)?

The most recent SEC filing for Aramark (ARMK) was filed on September 10, 2026.